Company / Working Capital
Chemed Corp. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$15.5M
FY2025
5-year range
-$72.1M / $188.8M
FY2021-FY2025
Trend
-85.8%
vs FY2024
Sector context
#149 of 165
Health Care
What the data says
Among 165 Health Care companies, Chemed Corp. is in the bottom 10% for working capital. Working Capital has fluctuated over the past 10 years, ranging from -$72M in FY2021 to $189M in FY2023.
Based on SEC 10-K filings.
$15M in FY2025 with a 5-year CAGR of -12.6%.
Declined from $189M to $15M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -12.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 165This company $15.5M Sector average $814.4M
▼
-98.1% below sector average
Key checks
Key Insights
- 5-year CAGR of -12.6%, indicating a declining trend.
- In FY2025, working capital decreased 85.8% year-over-year.
- Ranks #149 out of 165 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $15.5M | -85.8% |
| FY2024 | $109.1M | -42.2% |
| FY2023 | $188.8M | +867.7% |
| FY2022 | -$24.6M | +65.9% |
| FY2021 | -$72.1M | -338.0% |
| FY2020 | $30.3M | +142.3% |
| FY2019 | -$71.5M | -124.8% |
| FY2018 | -$31.8M | -82.1% |
| FY2017 | -$17.5M | -804.6% |
| FY2016 | -$1.9M | +90.6% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026